S Marchesi, G Lupattelli, R Lombardini, AR … - Journal of Clinical Pharmacy and Therapeutics, 2003 - pt.wkhealth.com Results: Before treatment, post-prandial phase was characterized by an increase
in triglycerides (3·7 ± 1 mmol/L at baseline vs. 4·2 ± 1, 6·5 ± 1, 6·6 ±
2, and 5·3 ± 2 mmol/L after 2, 4, 6, and 8 h), a decrease in FMV (4·3 ± ... Cited by 25 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org KK Koh, MJ Quon, SH Han, JY Ahn, DK Jin, … - Hypertension, 2005 - Am Heart Assoc Mechanisms underlying biological effects of statin and angiotensin-converting
enzyme inhibitor therapies differ. Therefore, we compared vascular and metabolic
responses to these therapies either alone or in combination in patients ... Cited by 105 - Related articles - All 10 versions
K Kon Koh, J Yeal Ahn, S Hwan Han, D Kyu … - Atherosclerosis, 2004 - Elsevier We investigated the effects of fenofibrate, peroxisome proliferator-activated
receptors (PPARs) agonist, on endothelial function in patients with
hypertriglyceridemia. We administered placebo or fenofibrate 200 mg daily ... Cited by 42 - Related articles - All 6 versions
- ►ahajournals.org KK Koh, MJ Quon, SH Han, WJ Chung, JY Ahn … - Circulation, 2004 - Am Heart Assoc Methods and Results— This was a randomized, double-blind, placebo-controlled
crossover trial with 3 treatment arms (each 2 months) and 2 washout periods
(each 2 months). Forty-seven hypertensive, hypercholesterolemic patients ... Cited by 158 - Related articles - All 12 versions
K Ikewaki, J Tohyama, Y Nakata, T Wakikawa, … - Journal of atherosclerosis and thrombosis, 2004 - sinoas.com Address for correspondence: Katsunori Ikewaki, Division of Car- diology,
Department of Internal Medicine, Jikei University School of Medicine, 3–25–8
Nishi-shinbashi, Minato-ku, Tokyo 105–8461, Japan. E-mail: ... Cited by 34 - Related articles - BL Direct - All 3 versions
- ►ahajournals.org J Kim, KK Koh, MJ Quon - Arteriosclerosis, thrombosis, and vascular biology, 2005 - Am Heart Assoc Disorders of metabolic homeostasis including type 2 diabetes, obesity, and
dyslipidemias are characterized by both insulin resistance and endothelial
dysfunction. 1 Insulin resistance and endothelial dysfunction are also ... Cited by 46 - Related articles - All 8 versions
J Genest, J Frohlich, G Steiner - The American journal of cardiology, 2004 - Elsevier The Diabetes Atherosclerosis Intervention Study (DAIS) examined the effects of
fenofibrate or placebo on the progression of coronary artery disease (CAD) in
418 type 2 diabetic subjects with dyslipidemia. Fenofibrate use was ... Cited by 34 - Related articles - All 8 versions
MA Vincent, M Montagnani, MJ Quon - Current Diabetes Reports, 2003 - Springer Insulin has important vascular actions that regulate blood flow, in addition to
its classical actions to coordinate glu- cose homeostasis. Insulin-stimulated
production of nitric oxide in vascular endothelium results in capillary ... Cited by 90 - Related articles - BL Direct - All 2 versions
